Safety study of an experimental medication in healthy adults
Part of Immune system & allergy, Infections clinical trials.
This study tests an experimental medication in healthy volunteers to see how it is processed by the body and whether it is safe. You may not receive direct benefit, but your participation helps find better treatments for people with HIV.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- You are generally healthy, with no major medical conditions.
- Your weight is at least 40 kg (about 88 lbs) and your body mass index (BMI) is between 18 and 32.
- If you are a man, you agree to use contraception for 90 days after the study drug. If you are a woman, you must be unable to become pregnant.
- You have not used tobacco or nicotine products in the past 6 months and you do not drink more than 14 drinks per week (men) or 7 drinks per week (women).
- You have not participated in another investigational drug study recently, and you have not had a tattoo or cosmetic procedure on your injection site areas.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injectable drug (VH4011499) for safety and how the body processes it. It's for healthy adults without HIV, and participants will get either the study drug or a placebo (an inactive shot).
This is an early-stage safety study testing a new investigational drug (VH4770359) in healthy volunteers. Researchers want to understand how the body processes the drug and ensure it is safe and well-tolerated.
This study tests a new oral drug to see if it is safe and how the body processes it. It is for healthy adults without HIV, and results will help determine if the drug could be used for HIV prevention in the future.
This study tests a new long-acting medicine that may help prevent HIV. It is given as an injection, and the study checks how safe it is and how it works in healthy volunteers.
This early-stage study tests a new HIV medication (VH4524184) to understand how your body absorbs and processes it. You'll take a single dose of the medication with a small amount of radioactive tracer, which helps researchers track where the drug goes in your body.
This study is testing three experimental antibodies (ePGT121v1-LS, PGDM1400LS, and VRC07-523LS) that may help prevent HIV. It’s looking at their safety and how long they stay in the body. Healthy volunteers without HIV can join.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.